KCT0003984已完成未知
A Pilot Study to Evaluate Efficacy and Safety of Anterior Cervical Discectomy and Fusion using a Patient Customized Bio-ceramic Cage: A Prospective, single-arm, open-labeled, multi-center, Investigator-initiated trial
Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 7 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 7
研究概览
简要总结
The initial application success rate after surgery, the primary endpoint, was 100%, and all 7 cases showed a perfect anatomical match between the cervical endplate and clinical medical device. The secondary endpoint confirmed no subsidence or failure of the clinical medical device occurred. So all users rated it as 'very satisfied. However, only three patients visited at 1, 3, and 6 months, one at 1 and 3 months, and one at a month, and the rest didn't. It was a bit disappointing in the evaluation.
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 79(Year)（—）
- 性别
- All
入选标准
- •1. Adult men and women aged 19 to 79 year-old. (19 ? Age < 80)
- •2. The following cervical disc disease and degenerative disease associated with the following clinical signs and symptoms require anterior cervical disc removal and fusion:
- •a) Symptoms and signs of radiation to one or both arms (pain, abnormal sensation or paralysis due to the distribution of certain nerve roots) or signs or symptoms related to acute or chronic myelopathy.
- •b) If there is an imaging diagnosis of cervical intervertebral disc herniation or/and bony scar formation(cervical spine 3-4 to cervical spine 7-thoracic spine 1) in one or both segments associated with clinical signs and symptoms of a)
- •3. A person who is willing to participate in the examination, and visit the hospital for all observation period.
- •4. A person who has voluntarily signed a written consent by hearing about the purpose and method of this clinical trial.
排除标准
- •1. Symptom of radiating or myelopathy are uncertain and only cervical pain is present.
- •2. A person with a history of malignant tumors (if the disease has been cured and has not recurred in the past 5 years)
- •3. If patient is pregnant or lactating, or is a child of childbearing age, patient does not agree to maintain contraception for the duration of the trial.
- •4. Chronic taking steroids, corticosteroids (eg, those taking Dexamethasone 10 mg / day for more than 4 weeks)
- •5. Persons with history of hypersensitivity to BGS-7 and titanium.
- •6. Those who are diagnosed with the following diseases and considered to be difficult to proceed
- •a. Spinal deformity
- •b. Unregulated diabetes, hypertension
- •c. Severe mental illness, epilepsy
- •d. Drug abuse and severe alcoholic
- •e. Severe heart disease or liver dysfunction
- •f. Metabolic disorders: severe osteoporosis (mean T-score <-3.0 on DEXA bone mineral density), rickets, osteomalacia, pituitary dysfunction, (para-)thyroid dysfunction, limb compartment syndrome,
- •g. Patient with infectious disease or blood disease who are at high risk of recurrence
- •7. Those who are deemed to have difficulty performing the clinical trial at the discretion of the examiners (such as those who can not perform the tests required in this study)
研究者
相似试验
已完成
不适用
A phase II study about the efficacy of an intervention of excercise therapy on the adjuvant chemotherapy for pancreatic cancer: Exercise-PC StudyJPRN-UMIN000030124Wakayama Medical University43
进行中（未招募）
不适用
Clinical trial using intraarticular administration of stem cells in meniscus injuryDegenerative meniscal lesionMedDRA version: 15.0Level: PTClassification code 10069364Term: Meniscal degenerationSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-006270-13-ESBanc de Sang i Teixits
尚未招募
不适用
mHag UTA2-1 loaded PD-L silenced DC vaccination after allo SCTNL-OMON22602VU University Medical Center17
进行中（未招募）
1 期
Tumor Antigen loaded Dendritic Cell Vaccination for hematological malignancies after allogeneic transplantatioMultiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL), Non hodgkin lymphoma (any grade), Acute myeloid leukemia (AML)MedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10025311 Term: Lymphoma (non-Hodgkin's) System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10009310 Term: CLL System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10001941 Term: AML System Organ Class: 100000004864EUCTR2018-002752-33-NLVU University Medical Center12
尚未招募
不适用
A phase I/II trial towards the safety and efficacy of preemptive vaccination with PD-L silenced, minor histocompatibility antigen UTA2-1 peptide-loaded Dendritic Cells after Allogeneic Stem Cell TransplantatioNL-OMON45903Vrije Universiteit Medisch Centrum17